TrialBMC cancer2017

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

Jana de Boniface et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.